Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$32.22 - $44.59 $26,484 - $36,652
-822 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$37.26 - $67.74 $17,773 - $32,311
477 Added 138.26%
822 $30,000
Q4 2020

Jan 13, 2021

SELL
$45.01 - $65.47 $85,473 - $124,327
-1,899 Reduced 84.63%
345 $20,000
Q3 2020

Nov 12, 2020

SELL
$35.79 - $48.81 $42,017 - $57,302
-1,174 Reduced 34.35%
2,244 $109,000
Q2 2020

Aug 13, 2020

BUY
$24.95 - $48.38 $76,671 - $148,671
3,073 Added 890.72%
3,418 $165,000
Q1 2020

May 12, 2020

BUY
$16.96 - $34.16 $5,851 - $11,785
345 New
345 $10,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $819M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.